Regional and disease specific human lung extracellular matrix composition.

Area of Science:

• Pulmonary Medicine
• Biochemistry
• Proteomics

Background:

• Chronic lung diseases, including COPD and IPF, involve extracellular matrix (ECM) remodeling.
• Previous studies analyzed whole decellularized lungs, lacking regional specificity.
• Understanding regional ECM differences is crucial for disease progression insights.

Purpose of the Study:

• To compare ECM composition across distinct lung regions (alveolar, airway, vasculature) in non-diseased, COPD, and IPF lungs.
• To identify region-specific ECM signatures and disease-induced alterations.
• To establish a methodology for isolating region-specific lung ECM biomaterials.

Main Methods:

• Post-decellularization dissection of human lungs (non-diseased, COPD, IPF).
• Mass spectrometry-based proteomic analysis of whole decellularized lung ECM (wECM) and regional ECM (aECM, airECM, vECM).
• Comparative analysis of ECM composition, focusing on collagens and basement-membrane proteins.

Main Results:

• Distinct ECM signatures were identified in different lung regions, primarily based on collagen and ECM glycoprotein profiles.
• Both COPD and IPF induced region-specific alterations in lung ECM composition.
• IPF lungs showed enrichment of type-III collagen and fibulin in alveolar-enriched ECM (aECM).

Conclusions:

• Lung anatomical regions possess unique ECM compositions.
• COPD and IPF cause distinct, region-specific ECM remodeling.
• The findings provide a dataset and methodology for identifying novel ECM therapeutic targets for chronic lung diseases.